4basebio PLC (LON:4BB - Get Free Report) insider Amy Walker acquired 1,151 shares of the business's stock in a transaction on Friday, February 28th. The shares were purchased at an average price of GBX 1,120 ($14.43) per share, for a total transaction of £12,891.20 ($16,612.37).
4basebio Trading Up 2.2 %
4basebio stock traded up GBX 25 ($0.32) during midday trading on Thursday, reaching GBX 1,140 ($14.69). The stock had a trading volume of 213 shares, compared to its average volume of 813. 4basebio PLC has a 52-week low of GBX 850 ($10.95) and a 52-week high of GBX 1,820 ($23.45). The company has a fifty day moving average of GBX 1,174.16 and a 200 day moving average of GBX 1,275.63. The firm has a market cap of £146.03 million, a price-to-earnings ratio of -1,461.54 and a beta of 1.09. The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47.
4basebio Company Profile
(
Get Free Report)
4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
Further Reading
Before you consider 4basebio, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 4basebio wasn't on the list.
While 4basebio currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
